Target intelligence / Profile preview

Macrophage lysosome and acidic intra-vesicular compartment

Molecular classification
Organelle, Cellular compartment
01

Overview

Macrophage lysosomes and acidic intra-vesicular compartments are specialized organelles essential for the degradation of macromolecules and the elimination of intracellular pathogens. These compartments maintain a highly acidic environment, typically with a pH between 4.5 and 5.0, which is maintained by the action of vacuolar H+-ATPases (v-ATPases) (Mindell, 2012, Annual Review of Physiology). In macrophages, these vesicles are central to the immune response, facilitating the destruction of phagocytosed bacteria and viruses and the subsequent processing of antigens for presentation to T cells (Flannagan et al., 2009, Nature Reviews Microbiology). Many pharmacological agents, particularly weak bases, act as lysosomotropic agents that selectively accumulate within these acidic spaces through a process known as ion trapping (de Duve et al., 1974, Biochemical Pharmacology). This accumulation can increase the internal pH, thereby inhibiting the activity of acid hydrolases, disrupting autophagic flux, and interfering with the replication of intracellular parasites or viral entry (Schrezenmeier & Dörner, 2020, Nature Reviews Rheumatology). While targeting these compartments is effective for treating autoimmune conditions like systemic lupus erythematosus and certain infections, chronic accumulation of drugs can lead to adverse effects such as phospholipidosis or organ-specific toxicities.

Other names
Lysosomal compartmentAcidic vesiclesPhagolysosomeEndolysosomal systemAcidic intra-vesicular organelles
02

Mechanism of action

Lysosomotropism and ion trapping leading to neutralization of intra-vesicular pH and inhibition of acid-dependent enzymes.

03

Biological functions

Protein degradationAutophagyPathogen killingAntigen presentationNutrient sensingHomeostasis
04

Disease associations

InfectionAutoimmune diseaseLysosomal storage diseaseCancerNeurodegenerative disease
05

Safety considerations

Drug-induced phospholipidosisRetinopathyCardiotoxicityImpaired immune clearanceNeuromuscular toxicity
06

Interacting drugs

Hydroxychloroquine

6 more in the full profile.

07

Biomarkers

Lysosomal-associated membrane protein 1 (LAMP-1)Lysosomal-associated membrane protein 2 (LAMP-2)Cathepsin D activityIntra-lysosomal pH

Beyond the preview

Go deeper on Macrophage lysosome and acidic intra-vesicular compartment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage lysosome and acidic intra-vesicular compartment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call